Last reviewed · How we verify
Midazolam Ketamine arm
At a glance
| Generic name | Midazolam Ketamine arm |
|---|---|
| Also known as | Analgosedation treatment |
| Sponsor | Azienda Sanitaria dell'Alto Adige |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Ketamine for Multiple Sclerosis Fatigue (PHASE2)
- Prospective IR-led Sedation Feasibility (PHASE1, PHASE2)
- Comparative Assessment of Oral Premedication Regimens in Pediatric Ambulatory Surgery (NA)
- Evaluation of Ketamine/Midazolam Sedation vs. Fentanyl/Midazolam Sedation for Image-Guided Percutaneous Procedures in Interventional Radiology (EARLY_PHASE1)
- The Effects of Sedatives on Tobacco Use Disorder Version 2 (EARLY_PHASE1)
- Nurse-Led BIS-Guided Sedation Protocol in Pediatric Intensive Care (NA)
- Ketamine in OCD: Efficacy and Effects on Stress and Cognition (NA)
- Comparative Analysis of Spinal Anesthesia Versus General Anesthesia for vNOTES (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |